Q2 2025 Update: SC Pharma Took a 4% Hit — Here’s Why

So, SC Pharma (SCPH) dropped about 4% after reporting their Q2 2025 update on August 7 even though revenue was up big both quarter-over-quarter and year-over-year. At first glance, that makes no sense, right? But here’s what I think is going on.

Want to read more?

Subscribe to bpiq.com to keep reading this exclusive post.

Subscribe Now